Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer

Overview

Journal N Engl J Med

Specialty General Medicine

Date 2017 Jul 13

PMID 28700263

Citations 2

Affiliations

Soon will be listed here.

Citing Articles

Mu Y, Meng Y, Du Y, Liu X, Zhang J Thorac Cancer. 2023; 14(34):3381-3388.

PMID: 37863840 PMC: 10693943. DOI: 10.1111/1759-7714.15130.

Kennedy S, Han J, Portman N, Nobis M, Hastings J, Murphy K Breast Cancer Res. 2019; 21(1):43.

PMID: 30898150 PMC: 6429830. DOI: 10.1186/s13058-019-1127-y.